课题基金 / 基金详情

项目摘要

项目成果

NATHANAEL Schiander GRAY的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Abstract: Fluorescence imaging is a powerful tool that permits visualization of specific cell states within a population; however, existing methods for fluorescence labeling are not experimentally accessible for many biological systems. Furthermore, fluorescent small-molecule sensors of cell state may provide a valuable alternative with significant benefits relative to existing methods for fluorescence imaging. The overall goal of this project is to create fluorescent small molecule ATP-site directed probes that can selectively label particular kinases and serve as imaging probes of normal versus pathological cell state. Protein kinases are in many ways ideal targets for the development of selective small molecule imaging probes for use in cancer biology. This is because protein kinases are involved in most cellular processes and changes in their localization, accessibility, and abundance are associated with changes in cellular state. Protein kinases have been used as biomarkers in cancer biology because the loss of endogenous kinase regulatory mechanisms by point mutations, gene deletions, gene amplifications, and chromosomal rearrangements has been well-established as crucial events in many cancers. The specific aims of this project are to: 1) Synthesize fluorescently-tagged kinase inhibitors capable of forming covalent bonds with ATP-site cysteine residues; 2) Use microscopy-based screening ofthe compounds prepared in Aim 1 to identify compounds that are selective-probes of normal and pathological cellular states and 3) Identify the intracellular target(s) of active compounds identified in Aim 2. This proposed is the extension of an ongoing collaboration between Drs. Nathanael Gray (Dana Farber Cancer Institute), Priscilla Yang (Harvard Medical School) and Wei Zhang (UMass Boston). All three are also members of the Dana Farber/Harvard Cancer Center. One of the strong points of this proposal is that each Co-Pl is responsible for one of the three Specific Aims allowing the project to be benefited by the balanced skills and expertise that each person and their subsequent institution brings to the partnership. Because all three investigators are eariy in their careers, Drs. Gray, Yang and Zhang will benefit from career development activities and mentors who are intemal and extemal. Additionally, the Training Core will significantiy contribute to this project.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Targeting CDK7 in CCNE1-amplified Ovarian Cancer
  • 批准号:
    10367792
  • 项目类别:
  • 资助金额:
    $72.71万
  • 财政年份:
    2022
  • 负责人:
    NATHANAEL Schiander GRAY
  • 依托单位:
Targeting CDK7 in CCNE1-amplified Ovarian Cancer
  • 批准号:
    10576332
  • 项目类别:
  • 资助金额:
    $68.47万
  • 财政年份:
    2022
  • 负责人:
    NATHANAEL Schiander GRAY
  • 依托单位:
Small molecule-induced degradation of dengue proteins as an antiviral strategy
  • 批准号:
    10472071
  • 项目类别:
  • 资助金额:
    $81.09万
  • 财政年份:
    2020
  • 负责人:
    NATHANAEL Schiander GRAY
  • 依托单位:
Small molecule-induced degradation of dengue proteins as an antiviral strategy
  • 批准号:
    10052821
  • 项目类别:
  • 资助金额:
    $82.98万
  • 财政年份:
    2020
  • 负责人:
    NATHANAEL Schiander GRAY
  • 依托单位:
国内基金
海外基金
新型光动力BODIPY衍生物靶向FDX1诱导铜死亡抑制骨肉瘤的机制研究
  • 批准号:
    2026JJ50597
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
    李劲松
  • 依托单位:
稠环连接的扩展卟啉BODIPY的合成及光物理性能研究
  • 批准号:
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
  • 依托单位:
Meso位C=N修饰的BODIPY类AIE光敏剂构筑及Aβ成像和光氧化治疗一体化研究
  • 批准号:
  • 项目类别:
    省市级项目
  • 资助金额:
    15.0万元
  • 批准年份:
    2024
  • 负责人:
    史文静
  • 依托单位:
基于BODIPY的低氧响应纳米诊疗系统用于三阴性乳腺癌精准免疫治疗研究
  • 批准号:
    2024Y9242
  • 项目类别:
    省市级项目
  • 资助金额:
    30.0万元
  • 批准年份:
    2024
  • 负责人:
    林雨翔
  • 依托单位: